Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 19 studies | 41% ± 19% | |
lung | 14 studies | 28% ± 10% | |
peripheral blood | 9 studies | 25% ± 11% | |
eye | 7 studies | 28% ± 14% | |
heart | 5 studies | 27% ± 7% | |
liver | 5 studies | 41% ± 16% | |
bone marrow | 4 studies | 20% ± 6% | |
pancreas | 3 studies | 39% ± 20% | |
lymph node | 3 studies | 17% ± 2% | |
intestine | 3 studies | 24% ± 8% | |
adipose | 3 studies | 47% ± 19% | |
kidney | 3 studies | 25% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 8538.97 | 459 / 459 | 100% | 48.16 | 1118 / 1118 |
esophagus | 100% | 9228.92 | 1445 / 1445 | 100% | 42.33 | 183 / 183 |
intestine | 100% | 10380.81 | 966 / 966 | 100% | 33.13 | 527 / 527 |
liver | 100% | 8047.92 | 226 / 226 | 100% | 27.18 | 406 / 406 |
prostate | 100% | 8483.80 | 245 / 245 | 100% | 38.73 | 502 / 502 |
stomach | 100% | 6756.70 | 359 / 359 | 100% | 34.64 | 286 / 286 |
thymus | 100% | 9267.26 | 653 / 653 | 100% | 36.27 | 605 / 605 |
uterus | 100% | 10595.65 | 170 / 170 | 100% | 42.22 | 459 / 459 |
lung | 100% | 10958.15 | 578 / 578 | 100% | 40.71 | 1153 / 1155 |
brain | 100% | 8794.05 | 2641 / 2642 | 100% | 43.54 | 704 / 705 |
bladder | 100% | 9542.52 | 21 / 21 | 100% | 35.32 | 503 / 504 |
kidney | 100% | 7105.10 | 89 / 89 | 100% | 32.63 | 898 / 901 |
skin | 100% | 9060.30 | 1809 / 1809 | 100% | 35.08 | 470 / 472 |
ovary | 100% | 8386.44 | 180 / 180 | 100% | 39.69 | 428 / 430 |
pancreas | 100% | 4773.86 | 327 / 328 | 99% | 37.21 | 177 / 178 |
adrenal gland | 100% | 8869.00 | 258 / 258 | 99% | 23.66 | 228 / 230 |
adipose | 100% | 8868.77 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 28.04 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 49.82 | 29 / 29 |
muscle | 100% | 8902.94 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 11132.66 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 38.21 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.94 | 1 / 1 |
blood vessel | 100% | 7070.15 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 5197.07 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 7463.80 | 904 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0006376 | Biological process | mRNA splice site recognition |
GO_0006397 | Biological process | mRNA processing |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0016441 | Biological process | post-transcriptional gene silencing |
GO_0061157 | Biological process | mRNA destabilization |
GO_0009792 | Biological process | embryo development ending in birth or egg hatching |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0035194 | Biological process | regulatory ncRNA-mediated post-transcriptional gene silencing |
GO_0007281 | Biological process | germ cell development |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_0017148 | Biological process | negative regulation of translation |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0097356 | Cellular component | perinucleolar compartment |
GO_0005634 | Cellular component | nucleus |
GO_0000900 | Molecular function | mRNA regulatory element binding translation repressor activity |
GO_0003729 | Molecular function | mRNA binding |
GO_0042835 | Molecular function | BRE binding |
GO_0003723 | Molecular function | RNA binding |
GO_0036002 | Molecular function | pre-mRNA binding |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CELF1 |
Protein name | CUGBP Elav-like family member 1 CUG triplet repeat, RNA binding protein 1, isoform CRA_c (CUGBP Elav-like family member 1) CUGBP Elav-like family member 1 (CELF-1) (50 kDa nuclear polyadenylated RNA-binding protein) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (Deadenylation factor CUG-BP) (Embryo deadenylation element-binding protein homolog) (EDEN-BP homolog) (RNA-binding protein BRUNOL-2) |
Synonyms | BRUNOL2 hCG_25183 CUGBP NAB50 CUGBP1 |
Description | FUNCTION: RNA-binding protein implicated in the regulation of several post-transcriptional events. Involved in pre-mRNA alternative splicing, mRNA translation and stability. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of cardiac isoforms of TNNT2 during heart remodeling at the juvenile to adult transition. Acts both as an activator and as a repressor of a pair of coregulated exons: promotes inclusion of the smooth muscle (SM) exon but exclusion of the non-muscle (NM) exon in actinin pre-mRNAs. Activates SM exon 5 inclusion by antagonizing the repressive effect of PTB. Promotes exclusion of exon 11 of the INSR pre-mRNA. Inhibits, together with HNRNPH1, insulin receptor (IR) pre-mRNA exon 11 inclusion in myoblast. Increases translation and controls the choice of translation initiation codon of CEBPB mRNA. Increases mRNA translation of CEBPB in aging liver (By similarity). Increases translation of CDKN1A mRNA by antagonizing the repressive effect of CALR3. Mediates rapid cytoplasmic mRNA deadenylation. Recruits the deadenylase PARN to the poly(A) tail of EDEN-containing mRNAs to promote their deadenylation. Required for completion of spermatogenesis (By similarity). Binds to (CUG)n triplet repeats in the 3'-UTR of transcripts such as DMPK and to Bruno response elements (BREs). Binds to muscle-specific splicing enhancer (MSE) intronic sites flanking the alternative exon 5 of TNNT2 pre-mRNA. Binds to AU-rich sequences (AREs or EDEN-like) localized in the 3'-UTR of JUN and FOS mRNAs. Binds to the IR RNA. Binds to the 5'-region of CDKN1A and CEBPB mRNAs. Binds with the 5'-region of CEBPB mRNA in aging liver. May be a specific regulator of miRNA biogenesis. Binds to primary microRNA pri-MIR140 and, with CELF2, negatively regulates the processing to mature miRNA . . |
Accessions | E9PKA1 ENST00000526419.1 ENST00000395292.6 [Q92879-3] ENST00000535982.1 ENST00000526277.1 ENST00000525841.5 E9PSH0 ENST00000528538.5 ENST00000530151.5 F5H3J7 ENST00000531165.5 F5H0D8 G5EA30 ENST00000528434.5 F5H4Y5 ENST00000395290.6 [Q92879-6] E9PQK4 ENST00000358597.7 [Q92879-1] ENST00000361904.7 [Q92879-3] F5H7M7 E9PKU1 ENST00000532048.5 [Q92879-4] ENST00000310513.10 [Q92879-2] ENST00000687097.1 Q92879 ENST00000543178.5 |